Strategic Technology & Process Transfer in Commercialising Biologics

Venue: Le Meridien Wien

Location: Vienna, Austria

Event Date/Time: Mar 12, 2014 End Date/Time: Mar 14, 2014
Report as Spam

Description

Technology and Process Transfer forms an inherent part of biopharmaceutical drug realisation and occurs at key stages throughout the product development lifecycle. It provides an important function in ensuring controlled knowledge, process and product transitioning between development and subsequent internal or outsourced clinical and commercial manufacturing stages. Technology Transfer can easily make the difference between a successful or failed project and it is therefore essential in getting it right the first time.

However there are still many Technology Transfer challenges from clinical stages to commercial manufacturing that do not have a standard practice. Delegates will learn how to best manage and design their control strategy in ensuring quality process transfer and scale up for commercialisation. As the fierce competition to reach the market continues, delegates are interested in how they could reduce time and cost while minimising the risk of failed manufacturing and benchmark from their peers.

By attending this exclusive marcus evans conference, delegates will benefit from finding tools to overcome bioprocessing, regulatory and manufacturing challenges to achieve a smooth transition into the market. Come and share your experiences with leading decision makers to streamline your clinical success!Technology and Process Transfer forms an inherent part of biopharmaceutical drug realisation and occurs at key stages throughout the product development lifecycle. It provides an important function in ensuring controlled knowledge, process and product transitioning between development and subsequent internal or outsourced clinical and commercial manufacturing stages. Technology Transfer can easily make the difference between a successful or failed project and it is therefore essential in getting it right the first time.

However there are still many Technology Transfer challenges from clinical stages to commercial manufacturing that do not have a standard practice. Delegates will learn how to best manage and design their control strategy in ensuring quality process transfer and scale up for commercialisation. As the fierce competition to reach the market continues, delegates are interested in how they could reduce time and cost while minimising the risk of failed manufacturing and benchmark from their peers.

Attending this premier event will enable you to:

  • Learn best-in-class business strategies to secure the future of your biologics
  • Discover new technologies and tools to improve commercial bioprocessing and manufacturing
  • Stay ahead of the regulatory progress and market access considerations
  • Gain insight from the CMO perspective and design a road map to collaborative manufacturing

Venue

Opernring 13-15
Vienna
Austria
MORE INFO ON THIS VENUE